These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6689397)

  • 1. [Molsidomine prevention of coronary artery spasm caused by alkalosis].
    Weber S; Kahan A; Pailleret JJ; Guérin F; Degeorges M
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):545-9. PubMed ID: 6689397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention with molsidomine of coronary artery spasm caused by alkalosis.
    Weber S; Kahan A; Pailleret JJ; Guérin F; Degeorges M
    Am Heart J; 1985 Mar; 109(3 Pt 2):704-7. PubMed ID: 3838408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of the alkalosis induction test for coronary artery spasm].
    Weber S; Pasquier G; Guiomard A; Lancelin B; Maurice P; Gourgon R; Degeorges M
    Arch Mal Coeur Vaiss; 1981 Dec; 74(12):1389-95. PubMed ID: 6800322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of arterial spasm during percutaneous coronary interventions through radial artery: the SPASM study.
    Varenne O; Jégou A; Cohen R; Empana JP; Salengro E; Ohanessian A; Gaultier C; Allouch P; Walspurger S; Margot O; El Hallack A; Jouven X; Weber S; Spaulding C
    Catheter Cardiovasc Interv; 2006 Aug; 68(2):231-5. PubMed ID: 16819768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

  • 9. [The normalizing effect of ECG in exercise tolerance tests under molsidomine in different dosages (author's transl].
    Jansen E; Klepzig H
    Med Klin; 1978 Jun; 73(26):983-6. PubMed ID: 672755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Absence of induced spasm by intracoronary injection of 50 micrograms acetylcholine in the right coronary artery: usefulness of 80 micrograms of acetylcholine as a spasm provocation test].
    Sueda S; Mineoi K; Kondo T; Yano K; Ochi T; Ochi N; Fukuda H; Kukita H; Kawada H; Matsuda S; Uraoka T
    J Cardiol; 1998 Sep; 32(3):155-61. PubMed ID: 9783236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new long-acting coronary artery dilator molsidomine and its metabolite SIN-1.
    Sobolski J; Vandermoten P; Stoupel E; Berkenboom G; Degre S
    Am Heart J; 1985 Mar; 109(3 Pt 2):700-3. PubMed ID: 3838407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molsidomine in ergometric tests (author's transl)].
    Röhl D; Lehmann KH
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1216-9. PubMed ID: 6893580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An improved exercise test in coronary-heart disease: effect of molsidomin on erogometrically controlled exercise (author's transl)].
    Blazek G; Heeger H; Kubicek F
    Dtsch Med Wochenschr; 1977 Jan; 102(3):81-4. PubMed ID: 832584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of molsidomine on exercise-ECG'S In coronary insufficiency (author's transl)].
    Grewe N; Stauch M
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1758-63. PubMed ID: 923459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic monitoring of left ventricular regional motion during hyperventilation and intravenous infusion of trometamol (tris) for detection of variant angina.
    Salomon P; Spring A
    Kardiol Pol; 2003 Oct; 59(10):302-11. PubMed ID: 14618214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of molsidomine in patients with coronary disease].
    Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H
    Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
    Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
    Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.